
usd jan pm et
summari compani one largest employe benefit organ
primari focu health care pharmaci benefit
price-to-earnings oper ep
past perform indic futur perform reli upon
analysi prepar equiti analyst
jan pm stock trade
oper revenu vs
full quarter
pharmaci revenu total vs
medic membership
yoy strong growth commerci
risk membership mostli off-set
drop govern risk flat membership
ci largest categori non-risk/servic
membership premium revenu grew
yoy despit low membership growth risk
medic expens grew yoy
significantli faster premium growth
caus medic cost ratio increas
basi point yoy howev addit
express script lower sg profil ci
sg ratio drop
acquisit express script top-thre
pharmaci benefit manag pbm close
decemb result deal ci
debt
share outstand grown yoy
addit debt cost share dilut
limit adjust ep growth yoy
ci durabl posit commerci
manag care posit revenu growth
outlook view remain neutral
share due express script deal
think integr larg pbm achiev
forecast synergi challeng
make earn outlook unclear
medium term polit risk relat pbm drug
rebat also mount view could
result new regul disrupt
ci util combin in-hous
pbm optumrx prior deal
achiev strong result
medic cost ratio basi point
given success question
whether ci purchas major pbm
worth larg amount sharehold dilut
debt requir
target ep estim
-- ci histor forward price-to-earnings averag due
integr risk regulatori scrutini
around pbm drug rebat risk view
includ rise medic util cost
trend unfavor regulatori chang
concentr put high risk
competit intens manag care ci taken
signific leverag integr risk associ
billion acquisit express script
drug price rebat model use pbm come
intens polit scrutini ci also
above-averag risk membership loss
econom slowdown view custom base
mostli group commerci contract lose
membership materi faster govern health
plan unemploy rise
feb ep estim base cfra oper earn
histor earn report compani report
stk
dividend paid sinc compani report
past perform indic futur perform
reli upon
forecast reliabl indic futur perform
redistribut reproduct prohibit without written permiss copyright cfra document intend provid person invest advic take account specif invest
object financi situat particular need specif person may receiv report investor seek independ financi advic regard suitabl and/or appropri make
invest implement invest strategi discuss document understand statement regard futur prospect may realiz investor note incom
invest may fluctuat valu invest may rise fall accordingli investor may receiv back less origin invest investor seek advic concern impact
invest may person tax posit tax advisor pleas note public date document may contain specif inform longer current use make
invest decis unless otherwis indic intent updat document
corpor overview fifth largest employe benefit organ term revenu
compani provid health care product servic well group life accid disabl
offer broad varieti benefit plan includ medic dental behavior health pharmaci
servic product medic product includ consum direct health plan cdhp hmo prefer
provid organ ppo among other health care product servic purchas
risk-bas plan custom pay fix premium carri risk health benefit
cost exceed premium revenu administr servic aso plan arrang
manag custom access health network custom self-fund medic cost aso
custom also sometim purchas stop-loss insur maximum exposur
medic cost limit exchang insur premium
decemb roughli medic custom base
approxim risk-bas custom pay premium servic custom pay
fee administr claim access network gener self-fund
larg major medic custom commerci custom commerci
million decemb total medic membership commerci busi
compris sever type custom account includ nation account multi-st
employ -base full-tim employe typic purchas aso fund
solut market account employ gener -base full-tim
employe purchas risk-bas aso plan select account employ gener
elig employe purchas aso stop loss insur coverag risk-bas plan
commerci medic membership grew grew
addit commerci busi provid manag care servic government-sponsor
custom govern segment compris approxim medic membership
decemb gener provid risk-bas plan compani govern segment offer
medicar advantag plan medicar part plan medicaid plan contract state
texa medicar supplement plan govern medic membership grew
beyond tradit medic benefit also provid benefit plan cover pharmaceut
behavior health dental group disabl life insur number custom
particip pharmaci benefit grew million million primarili
due addit custom gain complet express script combin
decemb acquisit express script pharmaci benefit manag came cost
approxim billion cash roughli equiti dilut pre-exist holder due
new equiti consider receiv express script holder primarili result express script
deal debt increas billion decemb billion decemb
addit health care benefit gener invest incom insur float
premium revenu paid advanc risk-bas plan yet paid medic claim
oper expens decemb held roughli billion cash
invest gener net invest incom billion
competit landscap accord insur inform institut roughli health
insur compani unit state estim rank fourth total medic
membership behind aetna own
gener compet nation for-profit manag care organ well
region local health plan provider-sponsor plan
financi trend oper revenu exclud invest incom increas billion
billion reflect three-year compound annual growth rate compound-annual-growth-rate
adjust pre-tax incom per share increas reflect
three-year compound-annual-growth-rate
chairman board
senior vice-president tax chief
redistribut reproduct prohibit without prior written permiss copyright cfra
base cfra proprietari quantit model
stock rank overvalu
analysi stock current worth base
cfra proprietari quantit model suggest
ci fairli valu
bullish sinc decemb technic indic ci
bullish
figur base fiscal year-end price
growth rate averag
lt debt capit
return equiti
balanc sheet data million usd
oper
long term debt capit
net incom revenu
return asset
return equiti
 global market intellig data may preliminari restat result discontinu operations/speci item per share data adjust stock dividend ep dilut
redistribut reproduct prohibit without prior written permiss copyright cfra
outlook health care servic
sub-industri next year neutral
think rise wage increas
low unemploy
support stabl growth demand health care
low septemb
remain near recent month even
econom condit weaken
grow possibl expect demand
health care servic remain steadi rel
mani industri
import health care consum
hand see threat headwind
profit health care servic
industri rise wage pressur labor
shortag reimburs pressur
rise health care spend incent
legisl regul find way
control cost health care servic
industri easi target cost
cut exampl initi lower
chang payment model dialysi treatment
recent bipartisan effort tackl surpris
bill unclear chang
dialysi payment affect firm like davita
long-run forecast surpris
bill legisl like hurt physician
outsourc group limit
time see opportun
health care servic firm make best
recent headwind exampl major pbm
merg major insur off-set
pressur notabl
acquir aetna aet ci acquir
express script esrx anoth exampl
opportun evid lab servic firm
respons continu signific
provid opportun acquir
smaller lab gain scale smaller
lab like falter diminish
also see risk investor sentiment
relat certain headlin discuss
medicar type health care
system fade among democrat
candid think could still
talk point elect
would hurt investor sentiment even
littl chanc becom realiti
next sever year think realiti
would hurt health care servic
would like lead lower averag
struck individu mandat
associ afford act
howev court avoid determin
much remain valid think
outcom remov possibl
worst-cas scenario health care servic
firm complet
gener benefit increas
insur coverag past sever year
elimin certain provis
could hurt industri howev
opinion unlik case
anticip industri ep growth
estim growth rate
 health
servic gain vs increas
 health servic index
increas vs decreas
base index
five-year market price perform jan
note sector sub-industri inform base
past perform indic futur perform
reli upon
laboratori corpor america
yield equiti
ltd
peer group compani stock select issu base market capit
note peer select base global industri classif standard market capit peer group list includ compani similar characterist may includ compani within
industri and/or engag line busi
redistribut reproduct prohibit without prior written permiss copyright cfra
et cfra maintain strong buy opinion share
corpor share pharmaci benefit manag pbm
includ ci insur trade pre-market today news
trump administr end pursuit elimin rebat
collect pbm mostli pass insur expect
elimin rebat sever impact profit pbm
move would certainli caus short-term industri friction
compani would modifi contract process respons
possibl rebat elimin also seem weigh heavili share
pbm past year on-going debat rise health care price
drug industri frequent point pbm industri key sourc
high drug price rebat elimin tabl expect trump
administr turn focu away pbm back toward drug
et cfra keep hold opinion share cigna corpor
drop target ep estim
-- ci histor forward price-to-earnings averag due integr risk
regulatori scrutini around drug rebat pbm rais ep
estim ep vs
beat consensu oper revenu versu
prior year period ci report first full quarter follow
decemb purchas express script ci gener revenu
pharmaci versu adjust ep yoy howev
inorgan growth off-set share dilut higher interest cost new
debt transit client despit histor low valuat
remain cautiou ci share concern synergi improv
competit deriv deal outweigh capit
cost especi given view polit uncertainti around pbm
busi model increas /colin scarola
analyst research note compani news
pm et cfra reiter hold opinion share humana inc
lift target price ep
estim maintain ep estim rais target price reflect
view investor sentiment health plan provid improv
significantli under-perform year manag
health index surg sinc end septemb vs gain
 think major driver shift
medicare-for-al candid lose support earli democrat primari
state accord fivethirtyeight poll averag fy
govern spend bill move congress elimin
health insur tax develop posit health plan provid
gener remain neutral share due concern may
buy market share ad benefit medicar plan without commensur
premium increas despit yoy growth medicar plan gross
profit health plan fell yoy /colin scarola
et cfra keep hold opinion share cigna corpor
lift price target ep
estim -- ci histor forward price-to-earnings averag due
integr risk high leverag rais ep estim
maintain start ep vs
yoy beat consensu oper revenu exclud
invest incom grew driven
decemb purchas pharmaci benefit manag express script
deal major driver earn increas ci also saw
yoy organ growth premium health plan oper revenu
gross margin health plan servic improv impress bp
yoy despit ci histor low valuat remain cautiou share
concern target synergi deal may materi
nearli one year remov close sg expens rise
sequenti rather move downward /colin scarola
pm et cfra maintain posit outlook manag health
industri share larg health plan provid
under-perform major indic week includ
ci sinc septemb compar drop
 think partial driven neg sentiment
speaker hous week announc impeach inquiri
presid trump view reaction due mani investor believ
impeach republican presid tip balanc power increas
odd democrat medicare-for-al propos becom law
elimin privat health plan think reaction misguid though
recent kaiser famili foundat poll estim voter
support elimin privat health plan favor even among
democrat voter major includ democrat speaker prefer
build implement accordingli maintain
posit outlook industri /colin scarola
pm et cfra keep hold opinion share cigna corpor
lift target ep estim ci
histor forward price-to-earnings averag due integr risk high
leverag rais ep estim keep
ep vs beat consensu oper revenu
vs second full quarter
follow decemb purchas express script ad quarterli
ci pharmaci revenu deal drove yoy jump oper incom
interest expens roughli new debt
share count increas use fund deal adjust ep
grew yoy note larg manag care peer
histor low valuat remain cautiou ci concern
synergi improv competit deal outweigh
capit cost /colin scarola
note research note reflect cfra publish opinion analysi stock time note publish note reflect view equiti analyst date time
indic note may reflect cfra current view compani
redistribut reproduct prohibit without prior written permiss copyright cfra
fiscal year analyst estim ci earn
usd quarter fiscal year ci
announc earn per share usd repres
total revenu estim fiscal year
analyst estim ci earn per share grow
usd
total
estimate
forecast reliabl indic futur perform
note compani earn outlook play major part invest decis global market intellig organ earn estim wall street analyst
provid consensu earn next two year well earn estim chang time note inform provid relat consensu
estim intend predict actual result taken reliabl indic futur perform
note tabl graph chart report cite refer sourc sourc global market intellig
redistribut reproduct prohibit without prior written permiss copyright cfra
sinc januari cfra equiti fund research servic
predecessor capit iq equiti research rank univers
common stock adr american depositari receipt adss american
depositari share base given equiti potenti futur perform
similarli rank asian european equiti sinc june
rank equiti accord individu forecast equiti futur total
return potenti versu expect total return relev benchmark
region index asia europ
base time horizon star design meet need
investor look put invest decis perspect data use
assist determin star rank may result analyst
model well intern proprietari model result dynam data
also known
 growth
stabil earn dividend deem key element establish
global market intellig earn dividend rank common stock
design capsul natur record singl symbol
note howev process also take consider certain
adjust modif deem desir establish rank
final score stock measur score matrix determin
analysi score larg repres sampl stock
rang score array sampl align follow
ladder rank
cfra earn per share ep estim reflect analyst project futur
ep continu oper gener exclud variou item
view special non-recur extraordinari also ep estim reflect
either forecast equiti analyst consensu averag ep estim
independ compil global market intellig data
provid cfra among item typic exclud ep estim
asset sale gain impair restructur merger-rel charg legal
insur settlement process research develop expens gain
loss extinguish debt cumul effect account
chang earn relat oper classifi
compani discontinu inclus item stock option
expens recur type charg may vari depend
factor industri practic analyst judgment extent
type data disclos compani
equiti analyst project market price given secur command
month henc base combin intrins rel privat
cfra equiti research produc distribut account research
analyt llc d/b/a cfra cfra us togeth affili
subsidiari cfra certain research produc distribut cfra
sdn bhd compani formerli known standard poor
malaysia sdn bhd cfra malaysia certain research distribut cfra uk
limit cfra uk cfra uk cfra malaysia wholly-own subsidiari
cfra us
abbrevi use equiti research report
ebit earn interest tax
redistribut reproduct prohibit without prior written permiss copyright cfra
p/nav price net asset valu ratio price-to-earnings-to-growth ratio pv present
 research develop roce return capit employ roe
return equiti
roi return invest
 return invest capit
roa return asset
wacc weight averag capit
dividend american depositori receipt adr american depositori
share adss net tax paid countri origin
reflect equiti analyst view given compani oper risk
risk firm abil continu on-going concern qualit risk
assess rel rank star univers
reflect risk factor relat compani oper oppos risk
volatil measur associ share price etf reflect
capitalization-weight basi averag qualit risk assess
assign hold fund
star rank system definit
total return expect outperform total return relev benchmark
notabl margin come month share rise price
total return expect outperform total return relev benchmark
come month share rise price absolut basi
total return expect close approxim total return relev
benchmark come month share gener rise price
absolut basi
total return expect under-perform total return relev
benchmark come month share price anticip
total return expect under-perform total return relev
benchmark notabl margin come month share fall
price absolut basi
north america relev benchmark europ
asia relev benchmark europ asia
